Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Shenni Holdings's annualizedNet Income for the quarter that ended in Sep. 2024 was $3.73 Mil.
Shenni Holdings's average Total Assets over the quarter that ended in Sep. 2024 was $10.43 Mil. Therefore, Shenni Holdings's annualized ROA % for the quarter that ended in Sep. 2024 was 35.76%.
The historical rank and industry rank for Shenni Holdings's ROA % or its related term are showing as below:
SNI's ROA % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.5 * Ranked among companies with meaningful ROA % only.
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Shenni Holdings ROA % Related Terms
Shenni Holdings ROA % Historical Data
* Premium members only.
The historical data trend for Shenni Holdings's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenni Holdings ROA % Chart
Shenni Holdings Annual Data
Trend
Mar23
Mar24
ROA %
-2.12
19.93
Shenni Holdings Semi-Annual Data
Mar23
Sep23
Mar24
Sep24
ROA %
0.00
6.28
27.86
35.76
SNI vs : ROA % Comparison
For the Medical Devices subindustry, Shenni Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenni Holdings ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenni Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where Shenni Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Sep. 2024) net income data.
ROA % is displayed in the 30-year financial page.
Shenni Holdings (SNI) has a ROA % of 35.76% as of Sep. 2024. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shenni Holdings and its competitors.
Is Shenni Holdings' ROA % too high?
Shenni Holdings' current ROA % is 35.76%. The Medical Devices & Instruments industry median ROA % is 0.50. Shenni Holdings' value of 35.76% is 7052% above this industry median.
How does Shenni Holdings' ROA % compare to ?
Shenni Holdings' ROA % of 35.76% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROA % is 0.50. Shenni Holdings' value of 35.76% is 7052% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.50, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenni Holdings's current ROA % of 35.76% is 7052% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shenni Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenni Holdings's current ROA % is 35.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenni Holdings stock overvalued right now?
Shenni Holdings (SNI) has a current ROA % of 35.76%. The current ROA % is 35.76% and 7052% above the Medical Devices & Instruments industry median of 0.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Shenni Holdings (SNI), the current ROA % is 35.76% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressBiopharmaceutical Industry Park, South Bridge Yongfeng County, Jiangxi Province, Jian, CHN, 331500
Shenni Holdings Ltd is a holding company. Through its operating subsidiaries in China, it is engaged in the business of the manufacture and distribution of urology medical devices and care products as well as the distribution of cardiovascular and cerebrovascular medical devices. Its products include Guide Wire, Catheter Sheath, and PTA Balloon Catheter. The company derives its revenue from three sources: (i) sales and distribution of urology medical devices (ii) sales and distribution of urology care products, and (iii) sales and distribution of cardiovascular and cerebrovascular medical devices.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNI has been successfully added to your 
